Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -10.390% | 1.778% | -2.966% | -15.963% | -18.214% | 148.104% | - |
| Vaxart Inc. | -10.850% | 25.519% | -6.686% | -50.813% | -51.543% | -77.310% | -92.577% |
| Larimar Therapeutics Inc. | -1.210% | -8.791% | -18.227% | -52.230% | -10.753% | 19.424% | -78.158% |
News
AMD Stock Slips Despite 30% Earnings Growth and Stronger-Than-Expected Guidance
Shares of Advanced Micro Devices (NASDAQ: AMD) are down 3.9% as of 7:42 p.m. ET in Tuesday's after-hours trading, following the chipmaker's release of its third-quarter 2025 report.
The report was
How AMD Stock Surged 58% Last Month
Shares of Advanced Micro Devices (NASDAQ: AMD) rose 58.3% in October 2025, according to data from S&P Global Market Intelligence. The semiconductor designer had a lot going on last month, divesting
500 Billion Reasons to Buy Nvidia Stock Hand Over Fist
Nvidia (NASDAQ: NVDA) may have been the poster child for artificial intelligence (AI) investing in 2023 and 2024, but that notion has been challenged in 2025. Companies like Broadcom and Advanced